German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing...
from NDTV News - World-news https://ift.tt/3s4efbK
Post a Comment